Latest study leverages new constructs for nuclear localization signal (NLS) sequences to improve editing efficiency in human immune cells.

Recently approved gene therapies offer patients one-time, potentially curative treatments for genetic diseases such as sickle ...

Newco Brink Therapeutics SAS is poised to work on the next chapter in genome editing after raising €3.5 million (US$4 million) in seed funding to discover and develop programmable recombinase enzymes.

New precision genome editing technologies are transforming the therapeutic landscape for patients with certain cancers and ...

The Birbal Sahni Institute of Palaeosciences (BSIP) in the city, in collaboration with the Zoological Survey of India (ZSI), ...

The Workshop on Genome Editing Tool Developments and Clinical Applications (#HKCRISPR25) was successfully held at the Hong ...

Learn about Brink Tx as it raises $4 million to go beyond CRISPR with engineered recombinases in CAR T therapy.

A US bio firm has announced the "rebirth" of an extinct carnivore called the dire wolf by using genome editing technology.

Earlier this month Scribe Therapeutics, a developer of CRISPR-based genome and epigenome editing platforms and candidates based on its CRISPR X-Editor (XE) and Epigenetic Long-Term X-Repressor ...